REVIEW PAPER
Environmental determinants of multiple sclerosis – a focused review
More details
Hide details
1
Student Scientific Society, Chair and Department of Neurology, Medical University, Lublin, Poland
2
Chair and Department of Neurology, Medical University, Lublin, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous
system (CNS) involving immune-mediated damage to myelin and axons. Its etiology is not fully understood, but both genetic susceptibility and environmental factors contribute to disease risk. The aim of the review is to summarize current knowledge on the most relevant environmental risk factors associated with MS
Review methods:
This review is mainly based on meta-analyses and original studies identified in PubMed and Google
Scholar database using key words such as ‘multiple sclerosis’, ‘risk factors’, ‘environmental’, and ‘pathogenesis’, published between 2020 – 2025. Relevant studies investigating environmental determinants of MS were selected and analyzed.
Brief description of the state of knowledge:
Prior infection with Epstein-Barr virus (EBV) shows the strongest association
with MS (odds ratio [OR] ~3.3). Other established risk factors include vitamin D deficiency, tobacco smoking (OR ~1.6), and obesity (OR ~1.2). These factors may contribute to MS development through immune dysregulation, chronic inflammation, and neurotoxic effects. Exposure during critical developmental periods, particularly childhood and adolescence, appears to be especially important. Additional factors, such as psychological stress and other viral infections, have been suggested, but current evidence remains limited.
Summary:
Environmental factors play a significant role in MS pathogenesis, likely through cumulative and interacting
effects. A better understanding of these factors may support the development of preventive strategies in the future and improve early risk assessment.
REFERENCES (35)
3.
Haki M, Al-Biati HA, Al-Tameemi ZS et al. Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore). 2024;103(8):e37297.
https://doi.org/10.1097/md.000....
4.
Holz A, Obi N, Pischon T et al. The Relation of Multiple Sclerosis to Family History, Lifestyle, and Health Factors in Childhood and Adolescence: Findings of a Case-Control Study Nested Within the German National Cohort (NAKO) Study. Dtsch Arztebl Int. 2025;122:348–354.
https://doi.org/10.3238/arzteb....
5.
Cortesi PA, Fornari C, Capra R et al. Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression Study. Value Health. 2022;25(9):1489–1498.
https://doi.org/10.1016/j.jval....
7.
Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520–32.
https://doi.org/10.1016/s1474–....
8.
Lane J, Ng HS, Poyser C et al. Multiple sclerosis incidence: A systematic review of change over time by geographical region. Mult Scler Relat Disord. 2022;63:103932.
https://doi.org/10.1016/j.msar....
9.
Simpson S Jr, Wang W, Otahal P et al. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(11):1193–1200.
https://doi.org/10.1136/jnnp-2....
10.
Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25–36.
https://doi.org/10.1038/nrneur....
11.
Endriz J, Ho PP, Steinman L. Time correlation between mononucleosis and initial symptoms of MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(3):e308.
https://doi.org/10.1212/nxi.00....
12.
Chakravorty S, Afzali B, Kazemian M. EBV-associated diseases: Current therapeutics and emerging technologies. Front Immunol. 2022;13:1059133.
https://doi.org/10.3389/fimmu.....
13.
Haahr S, Plesner AM, Vestergaard BF et al. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand. 2004;109(4):270–5.
https://doi.org/10.1046/j.1600....
14.
Schneider-Hohendorf T, Gerdes LA, Pignolet B et al. Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. J Exp Med. 2022;219(11):e20220650.
https://doi.org/10.1084/jem.20....
15.
Vitturi BK, Cellerino M, Boccia D et al. Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis. J Neurol. 2025;272(8):513.
https://doi.org/10.1007/s00415....
16.
Bjornevik K, Cortese M, Healy BC et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296–301.
https://doi.org/10.1126/scienc....
17.
Khalesi Z, Tamrchi V, Razizadeh MH et al. Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis. Microb Pathog. 2023;177:106031.
https://doi.org/10.1016/j.micp....
18.
Vitturi BK, Cellerino M, Boccia D et al. Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-Analysis. Eur J Neurol. 2025;32(11):e70398.
https://doi.org/10.1111/ene.70....
20.
Gombash SE, Lee PW, Sawdai E et al. Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective? Front Neurol. 2022;13:796933.
https://doi.org/10.3389/fneur.....
21.
Wang R. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis. J Transl Med. 2022;20(1):3.
https://doi.org/10.1186/s12967....
22.
Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
https://doi.org/10.1210/jc.201....
23.
Balasooriya NN, Elliott TM, Neale RE et al. The association between vitamin D deficiency and multiple sclerosis: an updated systematic review and meta-analysis. Mult Scler Relat Disord. 2024;90:105804.
https://doi.org/10.1016/j.msar....
24.
Yu XH, Lu HM, Li J et al. Association between 25(OH) vitamin D and multiple sclerosis: cohort, shared genetics, and Causality. Nutr J. 2024;23(1):151.
https://doi.org/10.1186/s12937....
25.
Jacobs BM, Noyce AJ, Giovannoni G et al. BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study. Neurol Neuroimmunol Neuroinflamm. 2020;7(2):e662.
https://doi.org/10.1212/nxi.00....
26.
Ehtesham N, Rafie MZ, Mosallaei M. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis. BMC Neurol. 2021;21(1):246.
https://doi.org/10.1186/s12883....
27.
Casal A, Suárez-Antelo J, Riveiro V et al. Smoking-related interstitial lung disease: A narrative review. Chron Respir Dis. 2024;21:14799731241291538.
https://doi.org/10.1177/147997....
29.
Sahraian MA, Bazmi E, Behnoush AH et al. Waterpipe Tobacco Smoking and Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2025;59(5):568–578.
https://doi.org/10.1159/000540....
35.
von Drathen S, Gold SM, Peper J et al. Stress and Multiple Sclerosis – Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression. Brain Behav Immun. 2024;120:620–629.
https://doi.org/10.1016/j.bbi.....